US stocks displayed stability near record highs in early trading on Tuesday, driven by stronger-than-expected economic growth data for the third quarter. The S&P 500 remained close to its all-time peak, while the Dow Jones Industrial Average registered a slight decline. Notably, shares of Novo Nordisk surged following the approval of a daily oral version of its popular weight-loss drug, Wegovy. This development highlights ongoing investor interest in the healthcare sector amid mixed market activity and holiday trading conditions.
Economic Growth Surprises Analysts
Recent government data indicated that the American economy expanded at a pace exceeding expectations during the July to September quarter. This growth has reinforced the perception of economic resilience, even with rising interest rates and a slowdown in factory activity. Positive economic indicators led to an increase in Treasury yields, suggesting that investors expect the Federal Reserve to adopt a cautious stance regarding further interest rate cuts. Consequently, the bond market responded with higher yields, reflecting ongoing economic optimism despite potential challenges ahead.
Stock Market Movements
During early trading, the S&P 500 hovered near its record high, while the Dow Jones Industrial Average dipped by 27 points, or 0.1%. The Nasdaq composite remained relatively unchanged, indicating a period of subdued trading activity. Ahead of the market’s opening, futures for the S&P 500, Dow, and Nasdaq were mostly flat, signaling a calm start to the trading day. This market tranquility is likely influenced by the upcoming holiday schedule, which includes early market closures on Wednesday and a complete shutdown on Thursday for Christmas.
Healthcare Sector Gains Momentum
Shares of Novo Nordisk experienced a significant increase following the approval of a daily pill version of its weight-loss drug, Wegovy, by US regulators. This approval represents a major milestone as it is the first oral medication approved for obesity treatment. The news has positively influenced investor sentiment not only for Novo Nordisk but also across the broader healthcare sector. Expectations are that this approval will enhance the company’s market position and potentially lead to increased sales, further driving interest in healthcare stocks.
Commodities and Global Market Trends
In the commodities market, gold prices continued to rise, reaching new record levels as investors sought safety amid global uncertainties. Silver prices also experienced gains, while oil prices edged higher following reports from the US Coast Guard regarding a sanctioned oil tanker in the Caribbean. Despite these recent increases, crude oil prices remain significantly lower for the year, largely due to weak demand indicators and sluggish factory activity. Meanwhile, overseas markets showed mixed results, with European stocks trading narrowly and Asian markets displaying modest gains, reflecting a varied global economic landscape.
Digihunt is not a financial advisor and this is not investment advice.









